Home688319 • SHA
add
Chengdu Olymvax Biopharmaceuticals Inc
Previous close
¥23.51
Day range
¥23.71 - ¥25.59
Year range
¥9.90 - ¥34.68
Market cap
10.18B CNY
Avg Volume
5.87M
P/E ratio
164.14
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 201.07M | 25.38% |
Operating expense | 114.84M | -1.85% |
Net income | 34.28M | 7.22% |
Net profit margin | 17.05 | -14.49% |
Earnings per share | — | — |
EBITDA | 78.62M | 115.92% |
Effective tax rate | 17.41% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 217.27M | -19.37% |
Total assets | 1.94B | 13.90% |
Total liabilities | 976.63M | 24.15% |
Total equity | 968.34M | — |
Shares outstanding | 406.77M | — |
Price to book | 9.96 | — |
Return on assets | 9.47% | — |
Return on capital | 13.28% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 34.28M | 7.22% |
Cash from operations | 52.78M | 1,454.28% |
Cash from investing | -58.29M | -5.27% |
Cash from financing | -9.14M | -157.22% |
Net change in cash | -14.65M | 66.15% |
Free cash flow | 12.04M | 114.07% |
About
Founded
Dec 11, 2009
Website
Employees
463
